Clinical Trial Update: A Study of Suvorexant in Patients With Multiple Sclerosis Fatigue and Insomnia [Phase 4]

View source ↗

Summary

Phase 4 study of suvorexant in patients with Multiple Sclerosis–related fatigue and insomnia has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue
• Insomnia
• Multiple Sclerosis

Drugs mentioned

• Suvorexant (suvorexant)

Snippet

Sponsor: Theodore R. Brown, MD MPH | Conditions: Multiple Sclerosis, Fatigue | Phase 4 | Status: COMPLETED | Results posted: 2025-02-03